X0202 4 2004-06-09 0 0001274913 INHIBITEX INC INHX 0001283390 EPLETT J DOUGLAS J 1165 SANCTUARY PARKWAY SUITE 400 ALPHARETTA GA 30004 1 0 0 0 Common Stock 2004-06-09 4 C 0 1045854.0000 A 1245854.0000 I See footnote Series D Convertible Preferred Stock 2004-06-09 4 J 0 331771.0000 A Common Stock 139400.0000 2108421.0000 I See footnote Series D Convertible Preferred Stock 2004-06-09 4 C 0 2108421.0000 D Common Stock 885892.0000 0 I See footnote Series E Convertible Preferred Stock 2004-06-09 4 C 0 380710.0000 D Common Stock 159962.0000 0 I See footnote The securities automatically converted on a 1-for-2.38 basis into Common Stock upon the closing of the initial public offering of the Issuer. The securities are owned directly by Essex Woodlands Health Ventures V, L.P. (the "Fund"), of which the Reporting Person is a general partner. In such capacity, the Reporting Person may be deemed to share voting and investment power with respect to the shares owned by the Fund. The Reporting Person disclaims beneficial ownership of the shares held by the Fund, except to the extent of his pecuniary interest therein. The securities convert on a 1-for-2.38 basis into Common Stock, giving effect to the recently completed 1-for-2.38 reverse stock split of the Common Stock. The securities were acquired upon the election of the Reporting Person to receive accumulated dividends on the Issuer's Series D Convertible Preferred Stock (the "Series D Stock") in Series D Stock. Such Series D Stock converted to Common Stock upon the closing of the initial public offering of Common Stock of the Issuer as described in Footnote 1. The securities are immediately convertible. The securities have no expiration date. /s/ Melissa P. Coyne attorney-in-fact for James Douglas Eplett Jr. 2004-06-09